Swiss pharma group Roche reported an increase in their global sales in the first half of the year by 5 percent, at a constant exchange rate, reaching CHF 22.9 billion due to the increased demand for cancer and autoimmune drugs, reports a press relese. According to Severin Schwan, Roche CEO, the good results are due to the performance of the cancer drugs, especially those against breast cancer, and the diagnostic division. The R&D division reported major progress as well both in Pharma and Diagnostic areas. )…) Considering the performance of Roche Group over the first six months, I am sure we will meet our targets for 2014,” stressed Schwan. For the current year, Roche forecasts an increase in sales of about 5 percent, for a constant exchange rate and higher dividends.
PM Ponta: Since I have been Prime Minister, I have had no data on existence of CIA prisons in Romania
Joint Bulgarian-Romanian government session:Romania, Bulgaria have bigger chances to succeed in all regional and European projects if together
Trilateral meeting Ponta-Borisov-Vucic: Romania, Bulgaria and Serbia could form Craiova Group, similar to Visegrad
Polish ambassador to Romania wants revitalisation of north-south corridor between Baltic and Black Sea
Iohannis: Recognition of Armenian people’s tragedy, a necessary signal for eliminating hatred, intolerance, racism, xenophobia
The Nine O’Clock Supplement
Nine O’Clock Announcements
5, Intrarea Armasului, District 1, Bucharest, Telephone: 317.71.36 / 317.71.35, Fax: 317.71.33 / 317.71.39
Nine O`clock Ads
Subscribe to RSS
Subscribe to RSS or enter you email to receive newsletter for news, articles, and updates about what's new.